An Aussie invention taking the hair loss industry by storm could be worth $10 billion annually should dermatologists hit an “achievable” uptake target of 2 per cent of balding people in key markets globally, new data shows.

Traditionally used as blood pressure medication, the use of minoxidil tablets to arrest balding and regrow up to 20 per cent of lost hair is growing in popularity across the Western world.